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Background: Recent studies have reported the development of neoatherosclerosis (NA) inside the stents in bare-metal stents (BMS) and drug-
eluting stents (DES). We sought to examine the relationship between cardiac troponin elevation after PCI and pre-PCI optical coherence tomography 
(OCT) findings of in-stent restenosis (ISR) lesion.
methods: We studied 80 ISR lesions in stable angina pectoris (SAP: n=76) and unstable angina pectoris (UAP: n=4) patients with a baseline 
normal cardiac troponin I (cTnI) level. The presence of pre-PCI OCT-defined lipid-laden neointima or calcification inside the stents was defined as NA. 
All lesions were divided into two groups (NA [n=33: 41%] and non-NA group [n=47: 59%]), and patient characteristics, stent type (BMS: 44, 55%, 
DES: 36, 45%), time since stent implantation (TIME; months), and post-procedural cTnI values were compared. Angiographic analysis was performed 
by quantitative coronary angiographic analysis (QCA).
results: There were no significant differences in the clinical presentations and QCA findings between the two groups. In NA group, TIME is 
significantly longer (NA: 57.1 [IQR: 16.0-113.4], non-NA: 9.9 [IQR: 8.0-11.8], P<0.01) and cTnI values were greater (NA: 0.19ng/mL [IQR: 0.05-
0.39], non-NA: 0.03ng/mL [IQR: 0.00-0.18], P<0.01) than in non-NA group. In DES lesions, NA lesions showed significantly greater cTnI elevation 
than in non-NA (NA in DES: 0.19ng/mL [IQR: 0.05-0.39] vs non-NA in DES: 0.00ng/mL [IQR: 0.00-0.09], P<0.01), whereas NA in BMS showed a 
non-significant greater cTnI elevations than in non-NA ISR (NA in BMS: 0.20ng/mL [IQR]: 0.09-0.37] vs non-NA in BMS: 0.10ng/mL [IQR: 0.00-
0.23], P=0.09). Peri-procedural myocardial damage (PMD) defined as elevated cTnI levels more than 0.30ng/mL after PCI was observed in 16 
patients (20%), and significantly more frequently in patients with NA than in those without NA (NA: 33%, non-NA: 11%, P=0.02). In multivariable 
analysis, NA (OR: 4.04; 95% CI: 1.20-13.60; P=0.02) and eGFR (OR: 0.96; 95% CI: 0.93-0.99; P=0.04) were independent predictors of PMD.
conclusion: NA is associated with cTnI elevation after elective PCI, especially in DES ISR lesions.
